Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Rabey, JM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 47 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Werber, EA; Rabey, JM
      The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia

      JOURNAL OF NEURAL TRANSMISSION
    2. Kushnir, M; Klein, C; Rabey, JM
      H reflex behavior in Parkinson's disease patients and patients with extrapyramidal and pyramidal signs combined

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    3. Pollak, L; Klein, C; Rabey, JM; Reichenthal, E
      Posturally evoked vomiting without nystagmus in a patient with Arnold-Chiari malformation

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    4. Pollak, L; Klein, C; Schiffer, J; Flechter, S; Rabey, JM
      Electroencephalographic abnormalities in aseptic meningitis and noninfectious headache. A comparative study

      HEADACHE
    5. Gilad, VH; Rabey, JM; Kimiagar, Y; Gilad, GM
      The polyamine stress response: tissue-, endocrine-, and developmental-dependent regulation

      BIOCHEMICAL PHARMACOLOGY
    6. Kushnir, M; Klein, C; Rabey, JM
      H reflex behavior in Parkinson's disease patients. Effect of stimulus duration

      PARKINSONISM & RELATED DISORDERS
    7. Rapaport, A; Sadeh, M; Stein, D; Levine, J; Sirota, P; Mosheva, T; Stir, S; Elitzur, A; Reznik, I; Geva, D; Rabey, JM
      Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesia

      MOVEMENT DISORDERS
    8. Rabey, JM; Sagi, I; Huberman, M; Melamed, E; Korczyn, A; Giladi, N; Inzelberg, R; Djaldetti, R; Klein, C; Berecz, G
      Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: A double-blind study as adjunctive therapy to levodopa

      CLINICAL NEUROPHARMACOLOGY
    9. Gilad, VH; Rabey, JM; Eliyayev, Y; Gilad, GM
      Different effects of acute neonatal stressors and long-term postnatal handling on stress-induced changes in behavior and in ornithine decarboxylase activity of adult rats

      DEVELOPMENTAL BRAIN RESEARCH
    10. Paleacu, D; Cohn, DF; Rabey, JM
      Cognitive evaluation of patients with chronic neurolathyrism

      PARKINSONISM & RELATED DISORDERS
    11. Rapoport, A; Stein, D; Schwartz, M; Levin, J; Stier, S; Elizur, A; Rabey, JM
      A trial of L-Deprenyl for the treatment of neuroleptic-induced parkinsonism

      JOURNAL OF NEURAL TRANSMISSION
    12. Kovner, F; Spigel, S; Rider, I; Otremsky, I; Ron, I; Shohat, E; Rabey, JM; Avram, J; Merimsky, O; Wigler, N; Chaitchik, S; Inbar, M
      Radiation therapy of metastatic spinal cord compression - Multidisciplinary team diagnosis and treatment

      JOURNAL OF NEURO-ONCOLOGY
    13. POLLAK L; SCHIFFER J; KLEIN C; MIROVSKY Y; COPELIOVICH L; RABEY JM
      NEUROSURGICAL INTERVENTION FOR CERVICAL DISK DISEASE IN DYSTONIC CEREBRAL-PALSY

      Movement disorders
    14. GILAD GM; GILAD VH; ELIYAYEV Y; RABEY JM
      DEVELOPMENTAL REGULATION OF THE BRAIN POLYAMINE-STRESS-RESPONSE

      International journal of developmental neuroscience
    15. POLLAK L; RABEY JM; GUR R; SCHIFFER J
      INDICATION TO SURGICAL-MANAGEMENT OF CEREBELLAR HEMORRHAGE

      Clinical neurology and neurosurgery
    16. MILO R; DEROSBO NK; MENDEL I; NADIV O; FLECHTER S; RABEY JM; BENNUN A
      ASSOCIATION OF THE T-CELL REACTIVITY TO MYELIN OLIGODENDROCYTE GLYCOPROTEIN (MOG) WITH DISEASE-ACTIVITY IN MS

      Neurology
    17. RABEY JM; AMIR I; TREVES TA; OBERMAN Z; KORCZYN AD
      DOPAMINE UPTAKE BY PLATELET STORAGE GRANULES IN FIRST-DEGREE RELATIVES OF TOURETTES-SYNDROME PATIENTS

      Biological psychiatry
    18. FLECHTER S:VARDI J; ALGUATI A; RABEY JM
      UNEXPECTED PRESENTATION OF MULTIPLE SCLEROSIS IN THE OLDER PEOPLE

      Archivio di psicologia neurologia e psichiatria
    19. RABEY JM; BASS H; BONUCCELLI U; BROOKS D; KLOTZ P; KORCZYN AD; KRAUS P; MARTINEZMARTIN P; MORRISH P; VANSAUTEN W; VANHILTEN B
      EVALUATION OF THE SHORT PARKINSONS EVALUATION SCALE - A NEW FRIENDLY SCALE FOR THE EVALUATION OF PARKINSONS-DISEASE IN CLINICAL DRUG TRIALS

      Clinical neuropharmacology
    20. POLLACK L; KLEIN C; RABEY JM
      THE DISTANCE SHORTENING PHENOMENON OR THE LAZY ARM SIGN AS A SUBTLE PYRAMIDAL SIGN

      Archives of neurology
    21. GILAD GM; WOLLAM Y; IAINA A; RABEY JM; CHERNIHOVSKY T; GILAD VH
      METABOLISM OF AGMATINE INTO UREA BUT NOT INTO NITRIC-OXIDE IN RAT-BRAIN

      NeuroReport
    22. RAPOPORT A; SCHWARTZ M; SHTEIN D; LEVIN I; STIR S; ELIZUR A; SAROVA I; RABEY JM
      L-DEPRENYL TREATMENT OF NEUROLEPTIC-INDUCED PARKINSONISM

      Schizophrenia research
    23. MOSEK A; RABEY JM; KUSHNIR M; KORCZYN AD
      PAINFUL CALF, MOVING FOOT

      Movement disorders
    24. RABEY JM; ORLOV E; SPIEGELMAN R
      LEVODOPA-INDUCED DYSKINESIAS ARE THE MAIN FEATURES IMPROVED BY CONTRALATERAL PALLIDOTOMY IN PARKINSONS-DISEASE - 2-YEAR FOLLOW-UP

      Annals of neurology
    25. MILO R; KERLERODEROSBO N; MENDEL I; NADIV O; FLECHTER S; RABEY JM; BENNUN A
      COPOLYMER-1 SUPPRESSES THE T-CELL PROLIFERATIVE RESPONSE TO MYELIN OLIGODENDROCYTE GLYCOPROTEIN

      Annals of neurology
    26. NEUFELD MY; RABEY JM; ORLOV E; KORCZYN AD
      ELECTROENCEPHALOGRAPHIC FINDINGS WITH LOW-DOSE CLOZAPINE TREATMENT INPSYCHOTIC PARKINSONIAN-PATIENTS

      Clinical neuropharmacology
    27. GILAD GM; GILAD VH; RABEY JM
      ARGININE AND ORNITHINE DECARBOXYLATION IN RODENT BRAIN - COINCIDENTALCHANGES DURING DEVELOPMENT AND AFTER ISCHEMIA

      Neuroscience letters
    28. RABEY JM; NEUFELD MY; TREVES TA; SIFRIS P; KORCZYN AD
      COGNITIVE EFFECTS OF SCOPOLAMINE IN DEMENTIA

      Journal of neural transmission
    29. INZELBERG R; NISIPEANU P; RABEY JM; ORLOV E; CATZ T; KIPPERVASSER S; SCHECHTMAN E; KORCZYN AD
      DOUBLE-BLIND COMPARISON OF CABERGOLINE AND BROMOCRIPTINE IN PARKINSONS-DISEASE PATIENTS WITH MOTOR FLUCTUATIONS

      Neurology
    30. RABEY JM; ORLOV E; KORCZYN AD
      COMPARISON OF FLUVOXAMINE VERSUS AMITRIPTYLINE FOR THE TREATMENT OF DEPRESSION IN PARKINSONS-DISEASE

      Neurology
    31. GILAD VH; TETZLAFF WG; RABEY JM; GILAD GM
      ACCELERATED RECOVERY FOLLOWING POLYAMINES AND AMINOGUANIDINE TREATMENT AFTER FACIAL-NERVE INJURY IN RATS

      Brain research
    32. MERIMSKY O; RABEY JM; INBAR M; CHAITCHIK S
      BREAST-CANCER ASSOCIATED BRACHIAL PLEXOPATHY - STILL A DIAGNOSTIC ANDTREATMENT CHALLENGE

      Oncology Reports
    33. RABEY JM
      2ND-GENERATION OF DOPAMINE AGONISTS - PROS AND CONS

      Journal of neural transmission. Supplementum
    34. ORLOV J; NEUFELD MY; RABEY JM; KORCZYN AD
      EEG FINDINGS WITH LOW-DOSE CLOZAPINE TREATMENT IN PSYCHOTIC PARKINSONIAN-PATIENTS

      Neurology
    35. INZELBERG R; NISIPEANU P; RABEY JM; KATZ T; ORLOV Y; KIPERVASSER S; SCHECHTMAN E; KORCZYN AD
      COMPARISON OF CARBERGOLINE (CBG) AND BROMOCRIPTINE (BCR) IN PARKINSONS-DISEASE (PD) PATIENTS WITH MOTOR FLUCTUATIONS

      Neurology
    36. RABEY JM; ORLOV E; SPIEGELMAN R
      LEVODOPA-INDUCED DYSKINESIAS ARE THE MAIN FEATURE IMPROVED BY CONTRALATERAL PALLIDOTOMY (PAL) IN PARKINSONS-DISEASE (PD)

      Neurology
    37. RABEY JM; TREVES TA; NEUFELD MY; ORLOV E; KORCZYN AD
      LOW-DOSE CLOZAPINE IN THE TREATMENT OF LEVODOPA-INDUCED MENTAL DISTURBANCES IN PARKINSONS-DISEASE

      Neurology
    38. GILAD GM; SALAME K; RABEY JM; GILAD VH
      AGMATINE TREATMENT IS NEUROPROTECTIVE IN RODENT BRAIN INJURY MODELS

      Life sciences
    39. RABEY JM; OBERMAN Z; GRAFF E; KORCZYN AD
      DECREASED DOPAMINE UPTAKE INTO PLATELET STORAGE GRANULES IN GILLES-DE-LA-TOURETTE DISEASE

      Biological psychiatry
    40. LEVY A; BRANDEIS R; TREVES TA; MESHULAM Y; MAWASSI F; FEILER D; WENGIER A; GLIKFELD P; GRUNWALD J; DACHIR S; RABEY JM; LEVY D; KORCZYN AD
      TRANSDERMAL PHYSOSTIGMINE IN THE TREATMENT OF ALZHEIMERS-DISEASE

      Alzheimer disease and associated disorders
    41. RABEY JM; NISSIPEANU P; INZELBERG R; KORCZYN AD
      BENEFICIAL EFFECT OF CABERGOLINE, NEW LONG-LASTING D-2 AGONIST IN THETREATMENT OF PARKINSONS-DISEASE

      Clinical neuropharmacology
    42. VERED Y; RABEY JM; PALEVITCH T; GROSSKOPF S; HARSAT A; YANOWSKI A; SHABTAI F; GRAFF E
      BIOAVAILABILITY OF LEVODOPA AFTER CONSUMPTION OF VICIA-FABA SEEDLINGSBY PARKINSONIAN-PATIENTS AND CONTROL SUBJECTS

      Clinical neuropharmacology
    43. RABEY JM; ORLOV E; KATZ T; KORCZYN AD
      BENEFICIAL EFFECT OF LOW-DOSE CLOZAPINE (CLOZ) IN THE TREATMENT OF LEVODOPA-INDUCED MENTAL DISTURBANCES IN PARKINSONS-DISEASE (PD)

      Neurology
    44. SHABTAI H; RABEY JM; TREVES T
      MOTOR AND MENTAL EVALUATION OF PARKINSONS-DISEASE (PD) IN VERY OLD-AGE

      Neurology
    45. NEUFELD MY; RABEY JM; SIFRIS P; PARMET Y; TREVES TA; KORCZYN AD
      EFFECT OF A SINGLE ACUTE INTRAVENOUS DOSE OF SCOPOLAMINE ON THE QUANTITATIVE EEG IN ALZHEIMERS PATIENTS AND AGE-MATCHED CONTROLS

      Neurology
    46. OBERMAN Z; RABEY JM; GRAFF E; KORCZYN AD
      DECREASED DOPAMINE (DA) UPTAKE BY PLATELET STORAGE GRANULES (PSG) IN GILLES-DE-LA-TOURETTE DISEASE (GDLT)

      Neurology
    47. RABEY JM; SHABTAI H; GRAFF E; OBERMAN Z
      [H-3] DOPAMINE UPTAKE BY PLATELET STORAGE GRANULES IN PARKINSONS-DISEASE

      Life sciences


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 09:26:43